品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A126366-10mg | 10mg | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
Moligand™, ≥99% |
|
|
阿拉丁 | A126366-50mg | 50mg | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
Moligand™, ≥99% |
|
|
阿拉丁 | A126366-200mg | 200mg | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
Moligand™, ≥99% |
|
|
阿拉丁 | A408287-1ml | 1ml | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
Moligand™, 10mM in DMSO |
|
|
麦克林 | A837230-10mg | 10mg | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
0.99 |
|
|
麦克林 | A837230-50mg | 50mg | 现货 | 1009298-09-2 |
AZD8055 AZD8055 |
0.99 |
|
|
麦克林 | A837230-200mg | 200mg | 订前询问 | 1009298-09-2 |
AZD8055 AZD8055 |
0.99 |
|
|
罗恩 | R024848-10mg | 10mg | 现货 | 1009298-09-2 |
[5-[2,4-二((3S)-3-甲基吗啉-4-基)吡啶... (5-(2,4-Bis((S)-3-methylmorp... |
99% |
|
|
MARY | MR135959-10mg | 10mg | 订前咨询 | 1009298-09-2 |
[5-[2,4-二((3S)-3-甲基吗啉-4-基)吡啶... (5-(2,4-Bis((S)-3-methylmorp... |
99% |
|
|
源叶 | S80013-5mg | 5mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | S80013-10mg | 10mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | S80013-25mg | 25mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | S80013-50mg | 50mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | S80013-100mg | 100mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | S80013-200mg | 200mg | 现货 | 1009298-09-2 |
AZD8055 (5-(2,4-bis((S)-3-methylmorp... |
98% |
|
|
源叶 | T92981-1ml | 1ml | 期货,请咨询 | 1009298-09-2 |
AZD8055 AZD8055 |
10mM in DMSO |
|
|
毕得 | BD226378-10mg | 10mg | 现货 | 1009298-09-2 |
(5-(2,4-双((S)-3-甲基吗啉)吡啶并[2,3... (5-(2,4-Bis((S)-3-methylmorp... |
96% |
|
|
毕得 | BD226378-50mg | 50mg | 现货 | 1009298-09-2 |
(5-(2,4-双((S)-3-甲基吗啉)吡啶并[2,3... (5-(2,4-Bis((S)-3-methylmorp... |
96% |
|
|
毕得 | BD226378-100mg | 100mg | 现货 | 1009298-09-2 |
(5-(2,4-双((S)-3-甲基吗啉)吡啶并[2,3... (5-(2,4-Bis((S)-3-methylmorp... |
96% |
|
|
毕得 | BD226378-5mg | 5mg | 现货 | 1009298-09-2 |
(5-(2,4-双((S)-3-甲基吗啉)吡啶并[2,3... (5-(2,4-Bis((S)-3-methylmorp... |
96% |
|
|